Path Neoplasm II (8)

The flashcards below were created by user mse263 on FreezingBlue Flashcards.

  1. How can the evolution of benign adenomas to carcinomas be characterized?
    it's marked by increasing & additive effects of mutations
  2. Agents that cause genetic damage & induce neoplastic transformation
    • • Chemical carcinogens
    • • Radiation energy
    • • Oncogenic viruses & other microbes
    • genetic damage lies at the heart of carcinogenesis
  3. What are the 2 categories of chemicals that can initiate carcinogenesis?
    • 1. direct acting agents
    • 2. indirect acting agents
  4. Direct Acting Agents
    • chemicals that do NOT require metabolic conversion to become carcinogenic
    • eg. alkylating & acylating agents, some of which are cancer chemotherapeutic agents (alkylating drugs: cyclophosphamide, chlorambucil, nitrosoureas etc.)
    • aka therapeutic agents themselves can cause new or subsequent, second forms of cancer
  5. Indirect-Acting Agents
    • pro-carcinogens that require metabolic conversion to an ultimate carcinogen before they become active
    • enzyme polymorphisms (eg. CYP-450) can be the reason behind why some people do or don't get cancer
    • examples: polycyclic/heterocyclic aromatic hydrocarbons, aromatic amines, amides, azo dyes, some natural plant & microbial products
  6. Initiation: 1st Step of Chemical Carcinogenesis
    • 1. cells are exposed to a significant dose of an 'initiator' (carcinogenic agent)
    • 2. rapid, irreversible mutation in the cell genome
    • 3. cell changes are now permanent → have the potential to give rise to tumors
    • 4. a promoter augments the carcinogenicity of the chemical initiator
  7. Initiator
    • causes non-lethal damage to DNA that cannot be repaired
    • mutated cell then passes on the DNA lesion to its daughter cell
  8. Can carcinogenesis occur before exposure to a promoter?
    • NO, an organism must be exposed to the promoter before carcinogenesis can proceed
    • the sequence of application of chemicals is critical, must go initiator → promoter → carcinogenesis/neoplasm formation
    • tumor won't form if the substances are given out of order
    • however exposure to a promoter can occur long after exposure to an initiator b/c its effect is long-lasting & irreversible
  9. How can all initiating chemical carcinogens be categorized?
    • as highly reactive electrophiles (E+ → have electron deficient atoms) that can react w/ nucleophilic (Nu:- electron rich) sites in the cell
    • they target DNA, RNA, proteins
  10. Promotion: 2nd Step of Chemical Carcinogenesis
    • the process of tumor induction in previously initiated cells by promoters (chemicals)
    • the effect of a promoter is ~short-lived & reversible
    • promoters do NOT affect DNA directly & are non-tumorigenic alone
    • they induce cell proliferation
  11. Promotor
    • pleiotropic chemicals involved in cell proliferation, clonal expansion, & aberrant differentiation of initiated cells
    • must follow the initiator & in doing so, produce a pre-neoplastic clone by inducing clonal expansion
    • (eg. phorbol esters, hormones, phenols, drugs)
    • Image Upload
  12. Ultraviolet Rays
    • cause skin cancers (squamous & basal cell carcinoma, possibly melanoma) by damaging DNA through the formation of pyrimidine dimers
    • the nucleotide excision repair pathway should normally reverse such damage
    • UV rays don't directly cause DNA mutations however they can cause changes in DNA that can further lead to mutations which may possibly result in cancer
    • a type of radiation carcinogenesis
  13. UV Ray Ranges
    • UVA: 320-400nm
    • UVB: 280-320nm
    • UVC: 200-280 nm
  14. What factors can effect the possible negative outcomes of exposure to UV rays?
    • 1. the type of UV (uvB light causes T base pairs next to each other to bond together into pyrimidine dimers)
    • 2. the intensity of exposure
    • 3. amount of melanin in skin
  15. Ionizing Radiation
    • electromagnetic (x & γ-rays) & particulate (α & β particles, protons, neutrons) radiation are all a type of radiation carcinogenesis
    • they cause mutations by Direct effect of radiation energy & an Indirect effect mediated by the generation of free radicals from H2O or O2
    • resulting damage to chromosomes by breakage, translocation, or point mutations → genetic damage + carcinogenesis
    • Image Upload
  16. Hierarchy of Cellular Vulnerability to Radiation- Induced Neoplasms
    • 1. myeloid leukemias, thyroid cancer in children
    • 2. breast, lungs, & salivary gland cancer
    • 3. skin, bone, GI tract cancer
  17. Viral & Microbial Carcinogenesis
    • a variety of DNA & RNA viruses are implicated in human cancer
    • oncogenic DNA Viruses encode proteins that bind regulatory proteins (eg. HPV, Epstein-Barr, Hep B)
    • oncogenic RNA Viruses (eg. human T-cell lymphotropic virus)
    • oncogenic microbes (eg. H.pylori is implicated in gastric adenocarcinoma & MALT lymphoma)
  18. Human Papillomavirus (HPV)
    • certain strands of an oncogenic DNA virus encode proteins that bind regulatory human proteins
    • are over 70 genetically distinct types of
    • HPV
    • some types (1, 2, 4, & 7) cause benign squamous papillomas (warts)
    • types 6 & 11 cause genital warts w/ low malignant potential
    • however types 16 & 18 are implicated in over 90% of squamous cell cancers of the uterine cervix & anorectal region as well as at least 20% of oropharyngeal cancers (high-risk types)
  19. How can papillomaviruses be oncogenic/cause malignancy?
    • by a rare events during which a portion of the viral DNA including E1 & E6, but NOT E2, integrates into the host cell genome
    • in these cells, continued expression of the early genes will enable the cell to divide continuously out of control & become a cancer cell (the genetic change becomes heritable)
    • infection by high-risk HPV types simulates the loss of tumor suppressor genes, activates cyclins, inhibits apoptosis, & combats cellular senescence
  20. Human T-cell Lymphotropic Virus (HTLV-1)
    • an oncogenic RNA Virus associated with a form of T-cell leukemia/lymphomas endemic in parts of Japan & Caribbean basin
    • is sporadic elsewhere, including the US
  21. What is HTLV-1's mechanism of carcinogenesis ?
    • it's not clear - the virus doesn't contain an oncogene nor is it integrated near a proto-oncogene
    • HTLV-1 encodes a viral transcription activation factor, TAX, which turns on genes for cytokines & their receptors in infected T-cells
    • a signaling loop is formed stimulating T-cell proliferation
    • polyclonal expansion of T-cells puts person at increased risk of developing additional mutations that can eventually give rise to a monoclonal T-cell tumor
  22. What was the 1st bacteria classified as a carcinogen?
    • Helicobacter pylori
    • is implicated in gastric adenocarcinoma & gastric lymphomas b/c it causes increased epithelial proliferation in combination w/ chronic inflammation
    • chronic inflammation/gastritis → gastric atrophy → intestinal metaplasia → dysplasia → cancer
  23. Cancer Cachexia (a clinical aspect of neoplasia)
    • progressive loss of body fat & lean body mass, profound weakness, anorexia, & anemia
    • may be caused by soluble factors such as cytokines produced by the tumor & the host
    • eg. macrophages secrete TNF in response to tumor cells, which themselves may release it
    • an imbalance in homeostatic mechanisms → cachexia
  24. Paraneoplastic Syndrome
    • when cancers produce remote effects that are not attributable to tumor invasion or to metastasis but are related to the synthesis of bioactive compounds by the tumor
    • found in 10-15% of cancer patients
  25. Cushing Syndrome
    • an endocrinopathic paraneoplastic syndrome associated w/
    • 1. small cell carcinoma of the lung
    • 2. pancreatic carcinoma
    • 3. neural tumors
    • results from prolonged exposure to high levels of ectopic ACTH (made by tumor)
  26. Hypercalcemia
    • another endocrinopathy w/ ectopic hormone production, specifically PTHrP (parathyroid hormone-related protein), TGF-α, TNF, & IL-1
    • may be seen in
    • 1. lung cancer (squamous cell carcinoma)
    • 2. breast carcinoma
    • 3. renal carcinoma
    • 4. ovarian carcinoma
    • 5. adult T-cell leukemia/lymphoma
  27. Nonbacterial Thrombotic Endocarditis
    • a hematological paraneoplastic syndrome seen in advanced cancers
    • it causes hypercoagulability
  28. Grading of Tumors
    • reflects cellular characteristics
    • is based on the degree of differentiation of the tumor cells & architectural features (aka does the tumor architecture look like its tissue of origin)
    • higher grade tumors are generally more aggressive
  29. Staging of Tumors
    • reflects the extent of spread
    • is based on the size of the primary lesion, its extent of spread to regional lymph nodes, & the presence or absence of vascular metastasis
  30. TNM system
    • T: site & extent of primary tumor
    • N: involvement of regional lymph nodes
    • M: distant metastasis
  31. Virtual Microscopy
    a method of posting microscope images on, & transmitting them over, computer networks allowing for independent viewing of images by large numbers of people in diverse locations
Card Set:
Path Neoplasm II (8)
2014-02-14 19:24:31
MBS Pathology
Exam 2
Show Answers: